A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

Clinical trial NCT07047144 · RECRUITING

Trial details

NCT number: NCT07047144
Sponsor: Scholar Rock, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Spinal Muscular Atrophy SMA Spinal Muscular Atrophy Type 2 Spinal Muscular Atrophy Type 3 Neuromuscular Manifestations Anti-myostatin

Start date: 2025-09-15
Primary completion: 2028-11-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.